pirtobrutinib
eli lilly
['pirto', 'cll']
median pfs for pirto just under 20 months with higher orr (80%) now that we have longer follow up - 14 months in penta-refractory cll #ash22 
Associate clinical professor at UC Irvine focused on CLL/SLL and CHIP/CCUS/MDS. Animal and nature lover. Tweets are my own.